Redwood Scientific Technologies, Inc. Modernizing medicine delivery with FDA-registered dissolvable oral strips

A B O U T R E D W O O D S C I E N T I F I C

Redwood Scientific is modernizing medication delivery by pioneering oral thin-film delivery technology.

Our dissolvable medicated strips provide a faster and more convenient solution for consumers.

The pharmaceutical industry currently lacks a modern, convenient, and efficient way to deliver medication.

The Problem with Pills: • Outdated technology• Pills require more medication to

work• Pills require water to consume• Pill bottles are often large and

inconvenient

Obsolete Technology Pills as we know them were invented

over 150 years ago

T H E P R O B L E M

S O L U T I O N : O R A L S T R I P S

Redwood Scientific is on the forefront of producing strip medication delivery.

Advantages of Oral Strips: • Convenient, quick dissolving measured dose• Superior stability, durability, and convenience• Film dissolves without need for water• Absorption is 3-10 times greater than oral tablets

O T C M A R K E T O P P O R T U N I T Y

Redwood Scientific produces superior over the counter (OTC) medication that millions of Americans need.

2.9 Billion retail trips are made annually to

purchase OTC products. (source: IRI, 2015)

93% of U.S. adults prefer to treat their minor

ailments with OTC medicines before seeking professional care.

87% percent of physicians believe OTC

medicines are an important part of overall healthcare.

$34 Billion U.S. pharmaceutical sales are

from OTC Sales.

60 Million people rely on OTC medicines

—off the shelf, without a prescription—to provide symptomatic relief for people who otherwise would not seek treatment.

81% of adults use OTC medicines as a first

response to minor ailments.

70-90% of all illness episodes are

addressed with self-treatment.

26 trips are made annually to purchase OTC

products versus but doctors visits on average only three times a year.

Source: Consumer Healthcare Products Association

C U R R E N T R E D W O O D O T C P R O D U C T S

Comfort Time - Aspirin for Adults TBX-Free - Smoking cessation Prolongz - Premature ejaculation Sumnusent - Sleep aidProduct-X - Male enhancementEupepsia Thin - Appetite Suppressant

Product OTC Market Size$4 Billion

$1 Billion

$6 Billion

$400 Million

$1 Billion (est.)

$64 Billion

Source: Consumer Healthcare Product Association

L E A D P R O D U C T S - T B X F R E E

TBX-FREE for Smoking Cessation • Affordable, effective, and easy to use• FDA registered• 1 Billion Market in North America alone• Anticipated 2.5% market share in 2017• Over 750,000 OTC retail opportunities

TBX-FREE has a success rate superior to the patch or gum.

N E W E S T P R O D U C T - E U P E P S I A T H I N

EUPEPSIA THIN - Appetite Suppressant • $64 Billion Market• Easy to use, all natural, and effective• FDA registered• Newest Redwood Scientific product• Over 750,000 OTC retail opportunities

Product Overview: • All-natural homeopathic formula• No dieting required• No lifestyle changes needed• Starts working in 20 seconds• Safe - No side-effects or drug reactionsStudies show Eupepsia Thin™, gives people a

chance to live a more active lifestyle and keep weight off.

C U R R E N T T B X - F R E E T R A C T I O N

Highlights • 15% growth month over month

• 21,000 current monthly TBX-FREE subscribers

• $210 Average Customer spending

• $44 Average customer acquisition cost

We are enjoying robust growth and high customer engagement

M A R K E T I N G

We utilize a combination of national television and online advertising, in addition to retail distribution.

Facebook Campaign

National TelevisionWe air daily advertisements on high traffic popular channels such as A&E,

Bravo, Esquire, and Oxygen.

We reach over 6.4 Million a month through Facebook ads to drive online

sales growth.

Sept Oct Nov Dec Jan Feb

R E D W O O D P R O D U C T P I P E L I N E

We currently have five FDA registered products on the market with three more on the way.

Brand Product R&D FDA Registration Product LaunchPremature Ejaculation

Smoking Cessation

Sleep Aid

Erectile Dysfunction

Dietary Supplement

Antidepressant

Adult Aspirin

Antibiotics

YES

YES

YES

YES

YES

YES

On Schedule for 2018

On Schedule for 2019

C O M PA R A B L E S

Zonnic - Nicotine Gum Zonnic produces nicotine gum and lozenges for smoking cessation. Niconovum AB, parent company of Zonnic, was purchased by Reynolds American Inc. in 2009.

Sale Price: $44M Revenue: Pending

Cure Pharmaceutical [CURR]- Thin Film Medication Cure is a developer and manufacturer of oral thin film medication delivery and specializes in innovative medicine delivery technologies. Market Cap:$163M Revenue: 84k

T H E R E D W O O D T E A M

Our Leadership Jason Cardiff

Eunjung Cardiff

Jacques Poujade

Chief Executive Officer and President

Marketing Director

Chief Financial Officer

Our Advisors

Auditors

SEC Council

Intellectual Property

FDA Council

Founder of Redwood Scientific Technologies. Founder of First Choice Media. Managed $100M advertising budget. Co-founder of Runaway Products. Developed and launched 7 top 10 infomercials. Founder of Top 5 most recognizable brands in the UK in 2009.

Eunjung opened and managed the New York branch of Cannella Response Television, the nation's largest direct response media placement agency and grew that business from $0 to nearly $30 million per year in fewer than 3 years. In addition to directing marketing efforts, Eunjung supervises the Redwood Scientific’s research and development activities – the bread and butter of Redwood.

Jacques’s extensive financial background, insights, and capabilities in building organizations make Jacques a valuable asset to Redwood’s management team. Some of Jacques’s companies are: First Allegiance Financial Group, which Jacques sold to Citi Mortgage Services (“CHCO” – Nasdaq); Lenders Direct Capital Corporation, which generated $2B in annual revenue; and Tri-Emerald Financial Group, present.